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The Controversy of Trade in Tobacco and Protection of Public Health,

The Controversy of Trade in Tobacco and Protection of
Public Health, A Study of Tobacco Control Measures and
Impacts on Trademark Practice: The Stricter, The Better?
Nattapong Suwan-in1*
Abstract
This paper investigates the anticipated trademark problems may result from tobacco control
regulations, particularly the warning label requirements implemented in WTO members and the
stricter regulation of plain packaging promulgated in Australia (“tobacco measures”). Following
the adoption of the Framework Convention on Tobacco Control (“FCTC”) in May 2003 (enforce
by February 2005), member countries tend to seek for possibilities to implement and use stricter
approach to achieve their public health policy. As the core concept and main goal of WTO is trade
liberalization, regardless of types of goods traded among members, whereas the stricter restriction on
trademark use means the prohibition of exploiting intellectual property rights of trademark owners,
TRIPS is thus unavoidably related and has been brought by tobacco companies to be against the
regulations, claiming that this poses unjustifiable trade barriers to business and denying its legitimacy
in corresponding to the WTO obligations. To what extent the FCTC instructs or entitles members to
pose barriers on trade in tobacco basing on public health purpose? Is there any correlation between
the FCTC, a framework adopted under World Health Organization (“WHO”), and the covered
agreements under WTO such as TRIPS?

Keywords: warning label, plain-packaging, TRIPS, tobacco control regulation,
Framework Convention on Tobacco Control, FCTC, public health policy

I. INTRODUCTION
Cigarette smoking is the single biggest avoidable cause of death and
disability in developed countries2. It has been, from time to time, rapidly increasing before the Second World War in the developing countries3 and becomes one of the biggest threats to current and future world
Lecturer in Law, School of Law, Assumption University of Thailand; LLB, iMBA-Law
(National Taiwan University of Science and Technology, Republic of China), PhD candidate (College of Law, National Taiwan University, Republic of China); Registered Lawyer
of Thailand; Notarial Services Attorney of Thailand. The author would like to thank Prof.
Lo Chang-fa for his advice during my research on the topic and also my former colleague,
Ms. Pattaravadee Kongcharoenniwat for her comments. The author can be reached at nattapong.suwan-in@au.edu and law.ghchen@gmail.com. The usual disclaimer applies.
2
See general Richard Edwards, the Problem of Tobacco Smoking, Clinical Review (2004),
available at http://www.bmj.com/content/328/7433/217.full (last visited Jun. 17, 2012).
3
P. Vateesatokit, B. Hughes and B. Ritthphakdee, Thailand: Winning Battles, but the War’s
Far from Over (2000), at 1, available at http://bmj-tobacco.highwire.org/content/9/2/122.
1 *

Volume 11 Number 4 July 2014

557

Jurnal Hukum Internasional

health as it does not affect only to people but also provide social and
unavoidable economic consequences. It is estimated that tobacco use
causes death for more than five million people a year and the number
could raise to more than eight million by 2030 unless measures are
taken to control the tobacco epidemic4.
To cope with the situation, various measures have been adopted to
control tobacco consumption5. This includes the early policy of warning label requirement (“health warning label”) that has been being used
in many countries as well as the recent development of the stricter rule
of tobacco control such as plain packaging (“plain package”) in Australia adopted in 20116. In Thailand, one of the early countries adopted the
control measures, because of a high consumption of tobacco in the country back in 1980s7, with internal force of public8, government passed the
Tobacco Products Control Act B.E. 2535 and the Non-Smokers’ Health
Protection Act B.E. 2535 which cover important provisions on i) total
ban on tobacco advertising, promotion and sponsorship, ii) prohibition
of youth access to tobacco (under 18), iii) disclosure of constituents and
emission of product to the Ministry of Public Health, iv) warning label
requirement with 9 pictorial health warnings, and v) prohibition of the
misleading descriptors such as “light” or “mild”, and so on.9. These followed after the first ban on tobacco advertising of Thai government by
including tobacco in the dangerous products category under the Consumer Protection Act which brought WTO dispute against Thailand on
GATT violation10.
While in US, the battle between big tobacco companies and US
government also brought some social awareness, evidenced in the lawfull (last visited Jun. 17, 2012).
4
Valentina S. Vadi, Global Health Governance at a Crossroads: Trademark Protection v.
Tobacco Control in International Investment Law, 48 Stan. J. Int’l L. 93 (2012), at 95-96.
5
Such as plain packaging, prohibition on promotion and advertisement, excise tax and etc.
6
Tania Voon, Acquisition of Intellectual Property Rights: Australia’s Plain Tobacco Packaging Dispute, E.I.P.R. 2013, 35(2), 113-118 (2013), at 113-114.
7
See Vateesatokit, Hughes and Ritthphakdee, supra note 2, at 2.
8
Id.
9
Thailand Tobacco Products Control Act B.E. 2535 (1992), sec. 4, sec. 8-9, and sec. 1113.
10
Panel Report, Thailand-Restriction on Importation of Internal Taxes on Cigarettes,
BISD/37/S/200 (Nov. 7, 1990).
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suits against the Food and Drug Administration (“FDA”) of the five
tobacco companies and R.J. Reynolds before the federal court in Kentucky. This happened soon after the President Obama signed the Family
Smoking Prevention and Tobacco Control Act (“FSPTCA”) in 2009,
which gives FDA authority to regulate tobacco products and amends
the Federal Cigarette Label Advertising Act to require cigarette makers
to place larger warning labels on their package. The claims based on
the ground of constitution and freedom of speech violation as well as
trademark (including trade dress) infringement11. In European Union
(“EU”), after the European Parliament and the Council of the EU have
adopted the Directive in 200112, label litigations were also raised to oppose by tobacco companies, claiming an infringement of Article295 EC
and member states’ systems of property ownership and a violation of
trademark provisions in TRIPS. Among various issues under consideration of the European Court of Justice (“ECJ”), a number of provisions
in TRIPS (i.e. Article 8 and Article 17) were ignored by court to strike
down to rule a precedent13 and left important issues undecided on its legitimacy. Along with stricter approach of the plain package being used
in Australia and the problem on uncertainty of legal compatibility of the
tobacco regulations with TRIPS, many contentious issues are yet unsolved but can likely be settled by the use of an interpretative tool available in the Vienna Convention on the Law of Treaty or VCLT14. At least
in the contexts of the warning label requirement and the plain packaging regulation, Articles 31 and 32 are undeniably relevant according to
TRIPS Article 64.1 that can be used for purpose of interpretation of the
arguments in Articles 8, 15, 16, 17 and 20. The research can be expected
to produce a reliable-legal-base answer and provide public analyzing
steps to base on. This is according to the customary rule of interpretation that TRIPS should, at the end, comply.

See generally Benjamin A. Hackman, On the Mark? Big Tobacco Asserts Property
Rights on Cigarette Packaging, 29 Penn St. Int’l L. Rev. 809 (2011).
12
Id., at 811.
13
Id., at 817.
14
See generally Vienna Convention on the Law of Treaties, 1155 U.N.T.S 331, 8 I.L.M.
679 (1969) [hereinafter VCLT] art. 31 and art. 32.
11
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II. INTRODUCTION TO FUNDAMENTAL RULES OF TRIPS
AND TRADEMARK
TRIPS or the Agreement on Trade-Related Aspects of Intellectual
Property Rights, constituting as Annex 1C of the Agreement Establishing the World Trade Organization (“WTO Agreement”)15, is the most
comprehensive international agreement on intellectual property protection16. With pressure from the United States Trade Representative
(“USTR”) through the use of the Special 30117 , TRIPS was concluded
and put into force in 1995, setting down a minimum standard of protection, in many forms of intellectual property (“IP”). With respect to
trademark, TRIPS recognizes trademark and provides protections detailed in Section 2 of Part II, Standards Concerning the Availability,
Scope and Use of IPRs, which covers seven provisions. Looking back
into TRIPS’ history, the regulation on trademark was not a major negotiation issue as controversial as patents. The major dissent between the
two sides of developed and developing countries in the field of trademark, in retrospect, was the extent to i) which rules complementing the
Paris Convention should be harmonized in a future agreement within
the GATT and ii) whether countries could continue establishing them at
the national level. As the consequence, the first compilation proposed
by the Chair was the substantive and procedural shortcomings of trademark protection in GATT, which revealed no major problems in Paris
Convention, and TRIPS was so drafted in the way to compile and provide some clarifications18.
Though TRIPS seems to complete what Paris Convention lacked, as
the parties initially put forward of their emphasis on the international
harmonization of IP standard and enforcement especially on patent, the
provisions of trademark, in comparison to patents, are likely regulated
imbalanced. That being said, though TRIPS acknowledges trademark as
WTO Agreement, Marrakesh Agreement Establishing the World Trade Organization,
Apr. 15, 1994, The Legal Texts: The Results Of The Uruguay Round Of Multilateral Trade
Negotiations 4 (1999), 1867 U.N.T.S. 154, 33 I.L.M. 1144 (1994), List of Annexes, Annex 1C: Agreement on Trade-Related Aspects of Intellectual Property Rights [hereinafter
WTO Agreement].
16
Terence P. Stewart, The GATT Uruguay Round: A Negotiating History, 478-79 (1993).
17
Id.
18
Id., at 207-208.
15
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a private right similarly to patent19 described in the Preamble, it seemingly fails to recognize “the enjoyment of right without discrimination”.
By comparing with patent provision in Article 27, whether this failure
is good or not, the terms carefully chosen should literally connote a
limited protection of trademark rights given to owners such in a manner
of being restricted to the Articles 15, 16, 17 and 20. This primary understanding is important to analysis on legitimacy of the tobacco measures
in the following chapter such as the warning label and plain package20.
As trademark is long recognized to function as to i) promote market and
sell products (advertising function), ii) refer to a particular enterprise
(differentiation function), iii) refer to a particular quality of the product
(guarantee function), and iv) indicate origin or source of one’s product from others’ (indication of origin function)21, impacts on trademark
functions and practical trademark system shall also be important that
deserve to mention and include in the study. This is in order to manifest
the consequences of tobacco measures in practice, a view of holisticapproach perspective that current research rarely touched upon.
III. DISPUTES ON TRIPS AGREEMENT AND TREATY INTERPRETATIVE TOOLS
DSB and Dispute Settlement Understanding (“DSU”) are not related to TRIPS merely because Article 64.1 so indicates but also the nature
of the dispute itself that lies upon the enforcement of the dispute settlement process promulgated in the DSU. Under umbrella of WTO, according to Article 3.2, the DSU provides that interpretation of all WTO
agreements, including TRIPS, shall be “in accordance with customAgreement on Trade Related Aspects of Intellectual Property Rights, Apr. 15, 1994,
Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, The Legal
Texts: The Results Of The Uruguay Round Of Multilateral Trade Negotiations 320 (1999),
1869 U.N.T.S. 299, 33 I.L.M. 1197 (1994) [hereinafter TRIPS Agreement] Preamble par. 4
provides: “Recognizing that intellectual property rights are private right…”.
20
See generally Trevor Stevens, Tobacco Plain Packaging Reforms: What They Mean to
Australian Trademark Law and our International Obligation (2011), available at http://
www.davies.com.au/pub/detail/501/tobacco-plain-packaging-reforms-what-they-meanfor-australian-trade-mark-law-and-our-international-obligations (last visited Jun. 18,
2012).
21
Wat Tingsamij, Explanation of Trademark Law, 3 (2002).
19
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ary rules of interpretation of public international law”22, known in the
name of the Vienna Convention. As evidenced in a number of reports of
Panel and Appellate Body (“AB”), discussion on TRIPS disputes usually begin with explanation of its correlation with the VCLT and end
up with application and then adjudication. In India-Patent Protection
for Pharmaceutical and Agricultural Chemical Products, the AB has
stated that “ . . .the duty of a treaty interpreter is to examine the words
of the treaty to determine the intentions of the parties. This should be
done in accordance with the principles of treaty interpretation set out
in Article 31 of the Vienna Convention. . .”.23 Thus, it is very rational
to start our analysis of legitimacy of the health warning label and plain
packaging regulations by reviewing the tools of interpretation, starting
with Article 31, the General Rule of Interpretation, of the provisions in
the VCLT24.
A. VCLT
Article 31: General Rule of Interpretation reads:
1. A treaty shall be interpreted in good faith in accordance with the
ordinary meaning to be given to the terms of the treaty in their
context and in the light of its object and purpose.
Understanding on Rules and Procedures Governing the Settlement of Disputes, Marrakesh Agreement Establishing the World Trade Organization, Annex 2, The Legal Texts:
The Results Of The Uruguay Round Of Multilateral Trade Negotiations 354 (1999), 1869
U.N.T.S. 401, 33 I.L.M. 1226 (1994) [hereinafter DSU] art. 3.2 provides: “The dispute
settlement system of the WTO is a central element in providing security and predictability
to the multilateral trading system. The Members recognize that it serves to preserve the
rights and obligations of Members under the covered agreements, and to clarify the existing provisions of those agreements in accordance with customary rules of interpretation
of public international law. Recommendations and rulings of the DSB cannot add to or
diminish the rights and obligations provided in the covered agreements”.
23
Appellate Body Report, India – Patent Protection for Pharmaceutical and Agricultural Chemical Products, 45, WT/DS50/AB/R (Dec. 19, 1997) [hereinafter India-Patent
for Pharmaceuticals Appellate Body Report]; Panel Report, India – Patent Protection
for Pharmaceutical and Agricultural Chemical Products, WT/DS50/R (Sept. 5, 1997), as
modified by Appellate Body Report.
24
Nattapong Suwan-in, Compulsory License, A Long Debate on TRIPS Agreement Interpretation: Discovering the Truth of Thailand’s Imposition on Pharmaceutical Patents, 7
Asian J. WTO & Int’l Health L. & Pol’y 225 (2012), at 231-232.
22
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2. The context for the purpose of the interpretation of a treaty shall
comprise, in addition to the text, including its preamble and annexes:
a) Any agreement relating to the treaty which was made between
all the parties in connection with the conclusion of the treaty;
b) Any instrument which was made by one or more parties in connection with the conclusion of the treaty and accepted by the
other parties as an instrument related to the treaty.
3. There shall be taken into account, together with the context:
a) Any subsequent agreement between the parties regarding the interpretation of the treaty or the application of its provisions;
b) Any subsequent practice in the application of the treaty which
establishes the agreement of the parties regarding its interpretation;
c) Any relevant rules of international law applicable in the relations between the parties.
Article 31 begins its core concept of interpretation with a plain
meaning against a broader context of holistic approach. Though there is
no term holistic or rational in the provision, its key captures the cornerstone that TRIPS must be interpreted in good faith in accordance with
the ordinary meaning to be given to the terms in their context and in the
light of its object and purpose. The wording suggests a logic of human
nature and cogent belief that interpretation must be first started somewhere with the ordinary terms and its meanings before extending its understanding to surrounding context as well as object and also purpose25.
As Prof. Susy Frankel described Article 31 as a “logical progression”
rather than a “hierarchy of legal norms”26 and the Appellate Body in
United States-Standards for Reformulated and Conventional Gasoline
has also confirmed that the need to apply other rules of international law
is unnecessary if Article 31.1 already provides the answer27, in consideration of the case of tobacco measures, our analysis shall then accordingly be scoped and focused on i) the treaty terms provided in TRIPS,
ii) its object and purpose provided in Article 8, iii) TRIPS’ preamble,
Id., at 232-233.
Susy Frankel, WTO Application of “the Customary Rules of Interpretation of Public
International Law” to Intellectual Property, 46(2) Va. J. Int’l L. 365, 386 (2006).
27
Appellate Body Report, United States – Standards for Reformulated and Conventional
Gasoline, WT/DS2/AB/R (Apr. 29, 1996).
25
26
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and iv) any subsequent agreement or practice or any relevant rules by
means of VCLT Article 31.3, in order to conclude if the measures are in
violation of provisions in TRIPS. To facilitate an interpretation, FCTC
and the Doha Declaration on Public Health (“Doha Declaration”) are
usually brought by implementing states to support their legitimacy and
compatibility with international obligations. To what extent FCTC can
be used to support government’s argument and to what extent FCTC
can entitle Member states to pose barrier on trade in tobacco, resulted
from the warning label and/or plain packaging requirement, as claimed
by Australia?28 In response to these, our analytical study in the following session will hence demonstrate the correlation of the FCTC, the
Doha Declaration, and TRIPS by means of Article 31 of the VCLT. As
the Doha Declaration was previously analyzed in the author’s article29
and it is nowadays confirmed by the AB’s decision in US-Clove Cigarettes that the Declaration can constitute as a subsequent agreement
subject to VCLT Article 31.3(a)30, the one problem left for determination is then the legal status of the FCTC. This is in order to solve the
TRIPS-violation-dispute questions.
B. Framework Convention on Tobacco Control: Its
Role and the Legal Status
1. Introduction to the Framework Convention on Tobacco Control —
The WHO Framework Convention on Tobacco Control or FCTC
is the first treaty adopted in World Health Organization by virtue
of Article 19 of the Constitution. Within the competence of the
organization, Health Assembly of WHO has authority to adopt
conventions or agreements with respect to any matter related31.
28
Australia Tobacco Plain Packaging Act 2011, No.148, 2011, Sec. 3 (1)(b) provides: “to
give effect to certain obligations that Australia has as a party to the Convention on Tobacco
Control”; See also Tania Voon, Flexibilities in WTO Law to Support Tobacco Control
Regulation, 39 Am. J.L. & Med. 199 (2013), at 204-205.
29
See generally Suwan-in, supra note 23.
30
See Benn McGrady, Revisiting TRIPS and Trademark: the Case of Tobacco (2012), at
2, available at http://ssrn.com/abstract=2144269 (last visited Jul. 29, 2013).
31
World Health Organization Constitution, 14 U.N.T.S 185 (1948) [hereinafter WHO
Constitution] art. 19 provides: “The Health Assembly shall have authority to adopt conventions or agreements with respect to any matter within the competence of the Organiza-
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To the first time that the Health Assembly has ever adopted, WHO
activated its constitution to develop the treaty to protect present and
future generations from health, social and economic consequences
of tobacco use32. Especially at this time when the global nature of the
tobacco epidemic required a global health governance mechanism
to effectively address the problem, the move represented a major
breakthrough in international public health law as WHO has never
before adopted conventions, despite of the instruments, for instance,
recommendations and regulations33. The convention reflects
scientific consensus on the lethal effects of tobacco smoke and
advances global cooperation for tobacco control34, so adopted on
May 21, 2003 in the 56th World Health Assembly and came into force
on February 27, 200535. It contains thirty-eight provisions in total,
regulates from the rules that govern production, sale, distribution,
advertisement, and taxation of tobacco to protection of environment
and settlement of disputes, just to name a few. Similarly to TRIPS,
FCTC provides minimum standard of requirements suggested to its
member. Because the FCTC, by law, binds only the state parties
that have ratified it (currently signed by 168 countries and of 177
ratifying countries36), in case where there is conflict with other treaty
regimes such as TRIPS, one may question about its legal status and
their correlation. This is especially when the FCTC suggests and
uses a non-obligatory language and even a very open-ended term.
tion. A two-thirds vote of the Health Assembly shall be required for the adoption of such
conventions or agreements, which shall come into force for each Member when accepted
by it in accordance with its constitutional processes”.
32
World Health Organization Constitution, Framework Convention on Tobacco Control
(2005) [hereinafter FCTC] art. 3 provides: “The objective of this Convention and its protocols is to protect present and future generations from the devastating health, social, environmental and economic consequences of tobacco consumption and exposure to tobacco
smoke by providing a framework for tobacco control measures to be implemented by the
Parties at the national, regional and international levels in order to reduce continually and
substantially the prevalence of tobacco use and exposure to tobacco smoke”.
33
See Vadi, supra note 3, at 100-101.
34
Id., at 101-102.
35
Wikipedia, the Free Encyclopedia, World Health Organization Framework Convention
on Tobacco Control, http://en.wikipedia.org/wiki/World_Health_Organization_Framework_Convention_on_Tobacco_Control (last visited Aug. 26, 2013).
36
Id.
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2. FCTC and its Legal Status subject to the Vienna Convention.
— FCTC, by relying on Article 19 of the Constitution37, is an
international convention or agreement legitimately resolved via
voting at the ratio of two thirds in majority by the assembly and
also in pursuit of the constitutional procedure38. To likely constitute
as a subsequent agreement according to points of views of some
scholars, claiming that FCTC can be a ground to strengthen and
support developing countries from departure of their burden of
disease from tobacco when this sort of tobacco control infrastructure
was absent, to our remark that the FCTC is a framework convention
under the WHO, while TRIPS is of or belongs to the WTO, to be
interpreted in conjunction with Article 31 of the VCLT, we found
difficulty to agree with the notion with two main reasons in support
of our argument.
First, FCTC and TRIPS are separated agreements, came to alive
for each individual purpose and launched in a different period of time.
While the FCTC, under WHO, has objectives to protect human health
and social consequences from tobacco use, TRIPS, on the other hand is
under WTO, mainly aimed to overcome the problem of discrimination
and generate free trade. As the previous decision made by AB in the
ACP-EC Partnership Agreement39 has previously ruled that “the material issues to consider a subsequent agreement by the meaning of Article 31.3(a) of the VLCT shall be (i) adopted by the same parties as of
the covered treaty,40(ii) characterized as an agreement bearing specifically upon the interpretation of a treaty which is, in the WTO context,
adopted pursuant to Article IX:2 of the WTO Agreement,41 and (iii) in
See supra note 30.
Id.
39
See generally Ministerial Conference, European Communities – The ACP-EC Partnership Agreement, WT/MIN(01)/15 (Nov. 14, 2001), available at http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_acp_ec_agre_e.pdf. (last visited Mar. 20, 2012).
40
World Trade Organization [WTO], 18 Dispute Settlement Reports 2008 7281 (June 28,
2010). “We agree with the Panel that the Doha Article 1 Waiver was adopted by the same
parties that approved the European Communities’ Schedule . . . .”
41
Id., at 7281-82 (the International Law Commission (ILC) describes a subsequent agreement within the meaning of Articles 31(3)(a) of the Vienna Convention as a further authentic element of interpretation to be taken into account together with the context”. In our
view, by referring to “authentic interpretation”, the ILC reads Article 31(3)(a) as referring
to agreements bearing specifically upon the interpretation of a treaty. In the WTO context,
37
38
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force as to interpret the covered treaty, not to connote the creation of
new obligation or modification of the covered treaty”,42 it is difficult to
say that FCTC is a subsequent treaty adopted pursuant to Article IX:2
of the WTO Agreement and in force to interpret TRIPS, the covered
agreement and treaty in dispute. This is though a scholar such as Prof.
Benn McGrady likely sees the provisions of FCTC being relevant in
interpretation of WTO law (so as its guideline), regardless of the fact
that it was made under WHO43. Without support from the Panel’s and
AB’s decisions in the recent case of US-Clove Cigarettes that concluded nothing explicitly regarding the legal status of the FCTC but literally
and merely, an acknowledgement and recognition of importance of tobacco control to Member countries44, therefore, it is thorny to conclude
that the FCTC can contribute to interpret TRIPS as a subsequent agreement though some proponents and implementing countries may so far
attempt to claim so45.
Second, the authority of the Health Assembly, according to Article
19 of the WHO constitution, is limited to only the adoption of convenmultilateral interpretations adopted pursuant to Article IX:2 of the WTO Agreement are
most akin to subsequent agreements within the meaning of Article 31(3)(a) of the Vienna
Convention . . . .” The Doha Declaration is also adopted pursuant to Article IX:2 of the
WTO Agreement because it was proposed initially through the TRIPS Council which in
turn made recommendations to the General Council and the General Council then reported
to the Ministerial Conference at Doha, which oversaw the functioning of the TRIPS (Annex 1C), and approved by consensus from all Members. Article IX:2 reads “The Ministerial Conference and the General Council shall have the exclusive authority to adopt
interpretations of this Agreement and of the Multilateral Trade Agreements. In the case of
an interpretation of a Multilateral Trade Agreement in Annex 1, they shall exercise their
authority on the basis of a recommendation by the Council overseeing the functioning of
that Agreement. The decision to adopt an interpretation shall be taken by a three-fourths
majority of the Members. ).
42
Id., at 7282.
43
Benn McGrady, Trade and Public Health: The WTO, Tobacco, Alcohol, and Diet, 36-37
(2011) “The basic obligations set out in a number of provisions have been supplemented
by guidelines that are an expression of best practice… assuming this to be the case, these
guidelines arguably fill out the content of basic FCTC obligations and would be relevant
in interpretation of WTO law in much the same way as the provisions of the FCTC itself”.
44
See Voon, supra note 27; See also McGrady, supra note 29, at 6; See also Tania Voon,
Note on WTO Appellate Body Report in US-Measures Affecting the Production and
Sale of Clove Cigarettes (2012), at 8, available at http://papers.ssrn.com/sol3/papers.
cfm?abstract_id=2143804 (last visited Jul. 31, 2013).
45
See Voon, supra note 43, at 204-205.
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tions or agreements with respect to matters within the competence of
the Organization. As the context imparts, “within the competence of
the Organization” and its ordinary meaning explain a limited scope of
authority that the assembly is allowed to restrictly be on a health related issue that shall become the gist of the agreement. The terms make
us understand that it is probably going too far to conclude that this
includes an interpretative function to explain trade related matter and
provision such specified in TRIPS.
Found in the same provision, apart from the subsection 3(a), the
VCLT further regulates other interpretative tools that are yet applicable
to the FCTC for purpose of interpretation. According to this issue, if
both parties in dispute adopt the FCTC provisions into their practice, it
is possibly that the FCTC can work as a subsequent practice (VCLT Article 31.3(b), or at least as a relevant rule of international law, pursuant
to the VCLT Article 31.3(c), defined by the International Law Commission46. However, viewing FCTC from the Article 31.3(c) perspective,
Prof. Tania Voon from Melbourne Law School likely sees some difficulties of applying the provision. They are i) the concept or definition
of the relevant rules of international law47, and ii) the interpretation of
the term “between the parties”, that both subsections (a) and (c) share
in common. Despite of the fact that a relevant rule of international law
can work across international organizations, such as the FCTC under
WHO to the interpretation of TRIPS under WTO48, to precisely prove
“Relevant” means that the rules are on the same subject matter or that in any way affect
the specified interpretation. The term “international law” without adjective should denote
public international law, rather than private international law which is specified and under
the principle of conflict of laws. Further, the phrase “applicable in the relations between
the parties” supports that even treaty obligations are covered by Article 31 (3) (c). That
was a particularly important matter where one treaty had to be interpreted in the light of
other treaties binding on the parties. Moreover, this phrase should refer to parties to the
treaty that is being interpreted.
47
Sebastian Mantilla Blanco, the Interpretation of the WTO Agreement (2010),
at 16, available at
http://www.javeriana.edu.co/juridicas/pub_rev/univ_est/
documents/4Interpretacion.pdf (last visited Jul. 29, 2013).
48
See Voon, supra note 27, at 205-206. “The uncertainty surrounding the scope of VCLT
Article 31(3)(c) need not pose a significant barrier to panels or the Appellate Body referring to the WHO FCTC in the course of resolving tobacco-related disputes, because Article 31(3)(c) does not provide the only means of referring to non-WTO law in the course
of interpretation…”; See also Panel Report EC-Measures Affecting the Approval and Marketing of Biotech Products, 7.68, WT/DS291/R, WT/DS292/R, WT/DS293/R (Sept. 29,
46
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its legal basis, Sebastián Mantilla-Blanco, in his research paper of the
Interpretation of the WTO Agreement, has given four guidelines for
consideration. Saying, first, such rule by its nature, must be relevant for
the interpretation of any international regime. Second, the rule must be
applicable in the relations between the parties. Third, the relevance of
non-mandatory rules must be assessed on a case-by-case basis, bearing in mind that their applicability to a specific relationship depends
on the objectively-ascertained intention of the parties. And forth, the
source of a rule will not affect its application in this context. As previously ruled by the Panel in EC-Biotech that the term “rules of international law” as used in VCLT Article 31.3(c) is broad enough to cover all
general sources of international law49, then the second criteria seems
holding the key in order to decide whether the FCTC can be classified
as a relevant rule of international law beAccording to this issue, the
Panel in EC-Approval and Marketing of Biotech Products50 had previously suggested that “the parties” shall mean all the WTO Members,
such that only a treaty to which all WTO Members are party could be
counted as a rule of international law pursuant to VCLT Article 31.3(c).
As the trend shows in i) the US-Clove Cigarettes that somehow demonstrates the correlation of FCTC and the WTO covered agreement, and
ii) the decision made by the Panel in EC-Approval and Marketing of
Biotech Products that somehow supports the use of FCTC for purpose
of interpretation51, together with iii) the recent opinions made by Pascal Lamy, the Director-General of WTO and Dr. Margaret Chan, the
Director-General of WHO, confirming that WTO rules and the implementation of the FCTC are actually in line and in fact compatible52, the
2006) [hereinafter EC-Approval and Marketing of Biotech Products]. “we recognize that
a proper interpretation of the term “the parties” must also take account of the fact that
Article 31(3)(c) of the Vienna Convention is considered an expression of the “principle of
systematic integration”… in a multilateral context such as the WTO, when recourse is had
to a non-WTO rule for the purposes of interpreting provisions of the WTO agreements, a
delicate balance must be stuck…”.
49
See Blanco, supra note 46, at 111.
50
See EC- Approval and Marketing of Biotech Products Panel Report, supra note 47.
51
Id., 7.94. “the mere fact that one or more disputing parties are not parties to a convention
does not necessarily mean that a convention cannot shed light on the meaning and scope
of a treaty term to be interpreted”.
52
WHO Framework Convention on Tobacco Control, WTO Rules and the Implementation of the WHO FCTC are not incompatible (2011), available at http://www.who.int/fctc/
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multilateral instruments such as the FCTC can (or should) at least be
relevant to determine “ordinary meaning” of particular terms pursuant
to the VCLT Article 31.1 as of the same logic of applying GATT’s necessity test to the term “necessary” appeared elsewhere in other treaties.
This is regardless of any practice followed by the parties (if any) that
can possibly be amounted to “subsequent practice” by means of VCLT
Article 31.3(b).

IV. LEGAL ANALYSIS ON LEGITIMACY OF HEALTH WARNING LABEL AND PLAIN PACKAGING REGULATIONS UNDER TRIPS
A. Health Warning Label Requirement and PlainPackaging Regulation on Tobacco
Under the Framework Convention on Tobacco Control, warning
label regulation is understood as a health warning requirement for
package of tobacco product which describes harmful effects of tobacco
use and regulated by competent national authority. Within different
jurisdictions and under different legal systems, the requirement of the
health warning label may be regulated in a different manner and level,
basing on national health policy specifically set by Member states that in
any case would deem legitimate as long as the standard in FCTC is met53.
Despite of the proportion of the warning label that the regulation may
require, there is a common form of pictorial warning and/or messages
imposed by WTO Members that can possibly amount to a restriction of
trademark use. In EU, according to the Directive adopted in 2001, the
label requirement mandates that the two most visible surface of every
cigarette package shall display a warning label at least 30 percent of
the most visible exterior. The proportion may be increased up to 35
percent if Members have official languages up to three54. Similar to the
FSPTCA of the US that requires top half of the front and rear panels of
wto_fctc/en/index.html (last visited Jun. 18, 2012).
53
FCTC art. 1(b)(i) provides: “(b) each unit packet and package of tobacco products and
any outside packaging and labelling of such products also carry health warnings describing the harmful effects of tobacco use, and may include other appropriate messages. These
warnings and messages: (i) shall be approved by the competent national authority…”
54
See Hackman, supra note 10, at 811-813.
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cigarette packs to contain one of the nine warnings, showing the risks
of smoking and a warning message, up to 70 percent of the warning
area55. While in Thailand, the Tobacco Products Control Act B.E.
2535 requires pictorial warning label at the proportion of 55 percent56.
Notwithstanding the percentage that each country’s law requires, the
regulations commonly limit the appearance of tobacco trademark that
may communicate to public and prevent owners from their use. Even
at this time when the plain packaging regulation was first introduced
in Australia, offering public a concrete form of a tighten measure that
steps beyond a simple health warning label to a smaller and stricter
scope by forcing the use of trademark (either via registration or use)
to be restricted in a single form of a plain, standard font, size, color
and identical design of word without device57, these bring a significant
question on legitimacy and compatibility of the regulations with the
international intellectual property obligations such as TRIPS.
B. Compatibility Of The Tobacco Measures With TRIPS
Among various arguments alleged by tobacco companies, criticisms
brought against tobacco measures, in the context of trademark, are
mostly and commonly on the claims of i) infringement and devaluation
of protected trademarks58, ii) denigration of trademark goodwill and
value through the use of pictorial warnings59, iii) expropriation of
property and private right by limiting their right to use60, and iv) its
incompatibility with the provisions of TRIPS, namely Article 15.4, 16,
Id., at 817-818.
See supra note 8, sec.12; See also Thailand’s Ministry of Public Health Notice of
Rules, Procedures, and Conditions for the Display and Content of Cigarette Labels (2009),
available at http://www.tobaccocontrollaws.org/files/live/Thailand/Thailand%20-%20
Cigarette%20Label%20Regs%202009.pdf (last visited Aug. 25, 2013).
57
See Vadi, supra note 3, at 96-97. “Plain packaging is a packaging regime that requires
the removal of colors, designs, and logos from cigarette packs while allowing the brand
name to be displayed in a standard font. Plain packaging is to reduce the incidence of
smoking by making cigarette packets less appealing. The Bill will require all cigarettes to
be sold in unattractive olive-green packs”; See also McGrady, supra note 29.
58
See Hackman, supra note 10, at 818-819.
59
See Vadi, supra note 3, at 106-107.
60
Sam Foster Halabi, International Trademark Protection and Global Public Health: A
Just-Compensation Regime for Expropriations and Regulatory Takings, 61 Cath. U. L.
Rev. 325 (2012), at 345.
55
56
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17, 20, and unjustification pursuant to Article 8.1. As the terms provided
in TRIPS are flexible and reserved for members’ implementation61,
TRIPS can thus be understood when the VCLT is brought to interpret
together with precedents ruled by Panel and AB that possibly guide
to a feasible solution may adopt by WTO62. To the extent that some
proponents view tobacco measures as a fair use exempted by Article
17, while opposers yet reject such argument, the following analysis
will therefore extract individual elements of the Articles, including
Article 15.4 and Article 20, and discuss all in details. With regards to
the challenge on the fair-use exception, Articles 16 and 17 of the TRIPS
provide:
TRIPS: Article 16 and 17
Art. 16.1 (Right Conferred)

Art. 17

The owner of a registered trademark
shall have the exclusive right to prevent
all third parties not having the owner’s
consent from using in the course of trade
identical or similar signs for goods or
services which are identical or similar to
those in respect of which the trademark is
registered where such use would result in
a likelihood of confusion…

Members may provide limited exceptions
to the rights conferred by a trademark, such
as fair use of descriptive terms, provided
that such exceptions take account of the
legitimate interests of the owner of the
trademark and of third parties

To view the warning label and the plain package regulations as fairuse, the conditions in Article 17 literally communicate the rule providing that the exception must be limited and be exception to the right
conferred. Without a right to protect, there is likely no exception would
be required. At the heart of the debate, the key would then underline
the ordinary meaning of the term “right conferred” in Article 16 and
TRIPS art.1.1 provides: “Members shall give effect to the provisions of this Agreement.
Members may, but shall not be obliged to, implement in their law more extensive protection than is required by this Agreement, provided that such protection does not contravene the provisions of this Agreement. Members shall be free to determine the appropriate
method of implementing the provisions of this Agreement within their own legal system
and practice”.
62
See supra note 22.
61
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capture their correlation to form a holistic understanding. Simply, the
provision states that the owner of a registered trademark shall have the
exclusive right to prevent a third party to use identical/similar mark on
similar products that would likely cause confusion to consumers. It is a
matter of fact that the right granted is the right of exclusivity which its
nature can exemplify the negativity or negative right to exclude the use
of trademark by someone else. As positive right can easily understand
as the right to use, none of the provision in the article entitles tobacco
companies to protest or claim when their right is restricted (or limited)
for such a vital purpose like public health. Furthermore, as it was earlier
mentioned in the EC-Protection of Trademarks and Geographical Indications for Agricultural Products and Foodstuffs 63, the Panel noted that;
“The limited exceptions apply to the right conferred by a trademark… Article 17 permits exceptions, to rights to exclude legitimate
competition, rather, they confer, inter alia, the right to prevent uses
that would result in a likelihood of confusion”
It can hence be argued that the claim earlier made by tobacco companies is in no way compliance with the provisions in TRIPS. Whereby
TRIPS provides flexibility in implementation to Member states via Article 1.1, positive right (i.e. right to use) is de facto provided at a domestic level during the process of national implementation64 rather than
in the international level. It then sounds unreasonable to claim that the
restriction of tobacco measures to use trademark would amount to a
violation of TRIPS. Added in support by the TRIPS’s preparatory work
in the light of VCLT Article 3265, the history also confirms our conclu63
Panel Report, EC-Protection of Trademarks and Geographical Indications for Agricultural Products and Foodstuffs, 7.651, WT/DS290/R (Mar. 15, 2005)
64
For instance, rights i) to authorize other persons to use trademark [Section 20(1)(b)], ii)
to bring an action for infringement of trademark [Section 26(1)(b)], iii) to display trademark on goods in respect of which the trademark is registered or on their packages or
containers [Section 26(1)(c)], v) to permit any person to apply trademark to goods [Section 26(1)(f)], v) to assign a registered trademark [Section 106(1)] and etc., as literally
explain in the Australian Trademark Act 1995, though there is yet a dissent on the nature
of trademark right appeared in the high court of Australia (See JT International SA v.
Commonwealth of Australia and British American Tobacco Australasia Limited v. The
Commonwealth). Other countries’ trademark laws, such as Thailand, are also promulgated
in the same manner.
65
VCLT art. 32 provides: “Supplementary Means of Interpretation: Recourse may be had
to supplementary means of interpretation, including the preparatory work of the treaty and
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sion, provided that the content of Article 16.1 is the result of the second
phase of discussion, triggered by the EC proposal of the draft in 1990,
which its emphasis was initially on the negative right, the claim of the
tobacco companies is hence unpersuasive and also unreasonable.
As interest in using trademarks is deeply connected to its capability
of being distinguish goods of undertakings in the course of trade from
of others at the gist of the trademark law, acknowledged by the Panel’s
decision in EC-Protection of Trademarks and Geographical Indications
for Agricultural Products and Foodstuffs 66, trademarks can yet be expected to perform its function though tobacco measures are in force67.
This is because the word-mark68 is yet allowed to indicate and communicate to consumers of its origin in a specific form, now prescribed
by specific law, namely the warning label and the plain package. TRIPS
does not oblige WTO Members to provide trademark holders with a
right to use their marks69.
TRIPS: Article 2
the circumstances of its conclusion, in order to confirm the meaning resulting from the application of Article 31, or to determine the meaning when the interpretation according to
Article 31: (a) Leaves the meaning ambiguous or obscure; or (b) Leads to a result which is
manifestly absurd or unreasonable”.
66
See supra note 62. “The TRIPS Agreement itself sets out a statement of what all WTO
Members consider adequate standards and principles concerning trademark protection. Although it sets out standards for legal rights, it also provides guidance as to WTO Members’
shared understandings of the policies and norms relevant to trademarks and, hence, what
might be the legitimate interests of trademark owners. The function of trademarks can be
understood by references to Article 15.1 as distinguishing goods and services of undertakings in the course of trade. Every trademark owner has a legitimate interest in preserving
the distinctiveness, or capacity to distinguish, of its trademark so that it can perform that
function. This includes its interest in using its own trademark in connection with the relevant goods and services of its own and authorized undertakings. Taking account of that
legitimate interest will also take account of the trademark owner’s interest in the economic
value of its mark arising from the reputation that it enjoys and the quality that it denotes”.
67
See general Halabi, supra note 59.
68
There are generally two types of trademarks, namely i) word marks (i.e. the characters
comprising the name of a brand) and ii) non-word marks (i.e. device, figurative or stylized
marks) such as logos and combined marks containing stylized letters, shape marks and
color marks. Some may refer to this non-word mark as a device mark. Please take Marlboro, a famous mark of tobacco products, as an example.
69
See EC-Protection of Trademarks and Geographical Indications for Agricultural Products and Foodstuffs Panel Report, supra note 62, para.7.610-7.611; See also McGrady,
supra note 29.
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Art. 20
The use of trademark in the
course of trade shall not be
unjustifiably encumbered by
special requirements, such as
use with another trademark,
use in a special form or use
in a manner detrimental to
its capacity to distinguish
the goods or services of one
undertaking from those of
other undertakings…

Interpretative Tool
VCLT Art.31.1
Ordinary Meaning:
1. There is a special requirement(s)
2. Such requirement is related to the course
of trade
3. Such requirement must be unjustifiably
(unjustified)
4. There is encumbrance arisen from such
requirement
5. Encumbrance is to the use of mark

Notwithstanding the exclusive right provided by TRIPS, the Agreement further recognizes trademark as a private right in paragraph four
of its Preamble70. It is an affirmation of capitalistic principle that is
translated into Article 2071 and aim to outlaw special requirement making use of trademark difficult in the course of trade and to save owners
from unjustified encumbrances. As touched many times by commentators in their research, Article 20 likely provides a strongest opposition
for tobacco companies to be against tobacco measures as its character
appears to be within scope of the Article 20. Found in the article, the
law requires a numbers of proof to show that i) there is a special requirement imposed, ii) the requirement imposed is related to the course
of trade, iii) what imposed in the course of trade is unjustified, iv) such
unjustified requirement causes encumbrance, and v) that encumbrance
influences the use of mark. “Requirement”, per its wording, is referring
to the act of demand, requisition, or requiring. While “encumbrance”
70

See supra note 18.

Nuno Pires de Carvalho, The TRIPS Regime of Trademarks and Designs, 89
(1993), at 45.
71
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would mean an obstruction that impedes or a burden72, the entire provision thus gives us an understanding that Article 20 shall denote a “special” demand or requirement, but not voluntariness73, in a sense that
a trademark use in the course of trade will be prohibited or restricted
and finally causes obstruction to trademark owners. To the extent that
the warning label and plain packaging regulations restrict the use of
trademarks in various formats prescribed by laws, it seems reasonable
to conclude that Article 20 would likely apply to both the measures that
prevent trademark from performing their functions.
Now turning us to the consideration of “unjustification” last mentioned in the article, “justified”, according to Wordnet dictionary, means
to show or prove to be just, right or reasonable. So, to be seen as “just”,
there must be a goal to be pursued. At least those that are prohibited
under GATT should not be considered legitimate or “just”74 in pursuit
of the law. The AB, in Brazil-Measures Affecting Imports of Retreaded
Tyres75, has mentioned that discrimination would be arbitrary or unjustifiably when i) the reasons given for discrimination bear no rational
connection to the objective falling within the purview of a paragraph
of Article XX, or ii) would go against that objective. Thus, in order to
conclude whether the tobacco measures are unjustifiable, there must
first be i) a public health policy and objective of invoking state that fall
within GATT Article XX(b)76 and ii) also a proof that the measures can
achieve such goal.
See generally Wordnet dictionary
See Panel Report, Indonesia-Certain Measures Affecting the Automobile Industry,
14.278, WT/DS54/R (Jul. 2, 1998).
74
Nuno Pires de Carvalho, The TRIPS Regime of Trademarks and Designs, 89 (1993),
at 329.
75
Appellate Body Report, Brazil-Measures Affecting Imports of Retreaded Tyres, 227,
WT/DS332/AB/R (Dec. 3, 2007).
76
General Agreement on Tariffs and Trade 1994, Apr. 15, 1994, Marrakesh Agreement
Establishing the World Trade Organization, Annex 1A, THE LEGAL TEXTS: THE RESULTS OF THE URUGUAY ROUND OF MULTILATERAL TRADE NEGOTIATIONS
17 (1999), 1867 U.N.T.S. 187, 33 I.L.M. 1153 (1994) [hereinafter GATT 1994] art. XX(b)
provides: “Subject to the requirement that such measures are not applied in a manner
which would constitute a means of arbitrary or unjustifiable discrimination between countries where the same conditions prevail, or a disguised restriction on international trade,
nothing in this Agreement shall be construed to prevent the adoption or enforcement by
any contracting party of measures: …(b) necessary to protect human, animal or plant life
or health…”.
72
73
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For long that justification has been treated as close to the necessity
test in many WTO case law77, this may imply a requirement of applying
the test in the proof of justification according to TRIPS Article 20, in
the light of the GATT, due to the WTO dispute procedure78. In the context of Australia, for example, the objectives of adopting the warning
label requirement is to i) increase consumer knowledge of health effects
relating to smoking and ii) to encourage the cessation of smoking and
to discourage uptake or relapse, along with a number of requirements
specified in the Trade Practice (Consumer Product Information Standards) (Tobacco) Regulations 2004. The measure is viewed, at least,
not against its objectives and likely consistent. It is deemed justifiable
according to the above interpretation with support from the case law.
While the plain package, the objectives set out in Section 3 of the Tobacco Plain Packaging Act 201179 is broad enough to possibly conclude
that the measure undertaken is also consistent (emphasis added). Likely,
the measure requirements related to public policy objective are usually
recognized and accepted to be justifiable (emphasis added) 80. Though
there is a number of scholars and researchers in support this notion81,
this paper argues that it is not always the case. Based on the VCLT ArSee Daniel Gervais, Analysis of the Compatibility of certain Tobacco Product Packaging Rules with the TRIPS Agreement and the Paris Convention (2010), at 29, available at
http://www.smoke-free.ca/trade-and-tobacco/Resources/Gervais.pdf (last visited Aug. 26,
2013).
78
Id., at 28.
79
See supra note 27, sec. 3 provides: “Objects of this Act, (1) The objects of this Act
are:(a) to improve public health by:(i) discouraging people from taking up smoking, or
using tobacco products; and (ii) encouraging people to give up smoking, and to stop using
tobacco products; and (iii) discouraging people who have given up smoking, or who have
stopped using tobacco products, from relapsing; and (iv) reducing people’s exposure to
smoke from tobacco products; and (b) to give effect to certain obligations that Australia
has as a party to the Convention on Tobacco Control.
(2) It is the intention of the Parliament to contribute to achieving the objects in subsection
(1) by regulating the retail packaging and appearance of tobacco products in order to:(a)
reduce the appeal of tobacco products to consumers; and (b) increase the effectiveness of
health warnings on the retail packaging of tobacco products; and (c) reduce the ability of
the retail packaging of tobacco products to mislead consumers about the harmful effects of
smoking or using tobacco products”.
80
See Carvalho, supra note 73, at 330; See also Alberto Alemanno and Enrico Bonadio,
Do you Mind My Smoking? Plain Packaging of Cigarettes under the TRIPS Agreement, 10
J. Marshall Rev. Intell. Prop. L. 450 (2011), at 464-465.
81
Id.
77
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ticle 31.1, to make our interpretation entirely and holistically coherent,
it is worth noting that interpretation should also be consistent with the
principle provision in TRIPS Article 8. The provision reads :
Art. 8.1 (Principles)
Members may, in formulating or amending their laws and regulations, adopted
measures necessary to protect public health and nutrition, and to promote the public
interest in sectors of vital importance to their socio-economic and technological
development, provided that such measures are consistent with the provisions of
this Agreement

Rather than overriding Members’ obligations82, Article 8 likely
works to interpret and mirror the main purpose of balancing the right
to promote public interest in sectors of vital importance to their socioeconomic and technological development, provided that such measures
are consistent with the provisions in TRIPS. With regards to this issue,
Member states can adopt measures to protect public health and nutrition
as long as it is “necessary” 83. As the term used in Article 8.1 is different
to the term used in the Article 20, by viewing the term on as-is basis, it
can be reasonably expected that the standard of proving or threshold of
justifiability should therefore be lower than the threshold of the necessity test84. Similar to the AB’s decision in Brazil-Measures Affecting
Imports of Retreaded Tyres, the invoking Member would then need to
demonstrate a genuine relationship of ends and means between the objective pursued and the measures at issue, such that the measure brings
about a material contribution to achieve its objective85. A Member may
also demonstrate this through evidence of a qualitative or quantitative
nature, given that no set requirements on the type of evidence that a
Member must have to support implementation of a measure and a member needs not prove that the measure will be effective in achieving its
82
83
84
85

See Gervais, supra note 76, at 17.
See supra note 75.
See McGrady, supra note 29, at 4.
See supra note 74, para. 145.
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objective because it can only be evaluated with the benefit of time86.
To prove “necessary”, Panel and AB have previously ruled in the
two important cases which set standard in their precedents. Here, USStandard for Reformulated and Conventional Gasoline in 1996 (Panel)
and US-Import Prohibition of Certain Shrimp and Shrimp Products in
1998 (AB), both have sum up the three major elements to qualify “necessary”. That to be said, in order to be necessary, i) there must be a policy
in respect of the measure designed to protect public health, ii) there is
correlation between the measure and policy objective that is necessary
to fulfill, and iii) such measure is the only way to accomplish the policy,
given that no other less restrictive measure than the one intended. Thus,
while there is no common statistical information confirms efficiency of
tobacco measures, especially the plain-packaging, towards tobacco consumption87, this paper found it difficult to conclude that the plain packaging regulation, in particular, would then be justifiable unless the objective
in public health is set at the maximum as to protect the entire nation from
being in touch with tobacco. To the extent that this research argues that
impacts resulted from the plain package on trademark use will likely be
tremendous88, by comparing to the case EC-Measures Affecting Asbestos and Asbestos-Containing Products89, it is still possible that the plain
packaging regulation can yet amount to the term necessary and justifiable
subject to Article 20 in the light of the TRIPS’s principle in Article 8.
Supported by the Panel’s decision in European Communities I90 and the
latter case of Thai Cigarette in 199091, the level of public policy objective
is therefore left up to Members to decide.
Id., para 151.
See Gervais, supra note 76, at 27.
88
See C. The Stricter, the Better? Impacts on Trademark System in Practice
89
Appellate Body Report, European Communities - Measures Affecting Asbestos and Asbestos-Containing Products, WT/DS135/AB/R (Mar. 12, 2001) [hereinafter EC-Measures
Affecting Asbestos and Asbestos-Containing Products]; Panel Report, European Communities - Measures Affecting Asbestos and Asbestos-Containing Products, WT/DS135/R
(Sep. 18, 2000).
90
See Carvalho, supra note 73, at 190. “…paragraph one of Article 8 reflects the fact that
the TRIPS Agreement does not generally provide for the grant of positive rights to exploit
for use certain subject matter, but rather provides for the grant of negative rights to prevent
certain acts. This fundamental feature of IP protection inherently grants Members freedom
to pursue legitimate public policy objectives…”.
91
See supra note 9.
86
87
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V. THE STRICTER, THE BETTER? IMPACTS ON TRADEMARK SYSTEM IN PRACTICE
Though the balance can be maintained via interpretative tool such
as ordinary meaning, object and purpose, and subsequent agreement,
i.e. the Doha Declaration, that recently confirmed in the US-Clove Cigarettes, it does not change the fact that there are likely impacts resulted from the imposition of tobacco measures. At this point of problem
where general research hardly touched on, as the use of trademark on
tobacco in the context of plain package is now limited to only the plain
text, while devices and figures are required to be taken down, the limitation thus raises a number of questions to courts, government registrars
and IP lawyers on how the measures are supposed to work in conjunction with current practice where the fact of “trademark use” (as opposed
to non-use) is very much important.
1. Trademark Use: Acquisition of Trademark Protection (Via Use)
Trademark use has long been acknowledged and recognized in
trademark law of its vital function on distinctiveness that relates to consumers’ capability of distinguishing source or origin of products. In the
context of trademark acquisition, many civil law system and almost
Anglo-American common law countries give trademark protection
through the use of a mark if it is capable of distinguishing one’s source
of product from others92. To the extent that the use of trademark is now
limited as the result of the plain packaging regulation, distinctiveness
is expected to be hard for marks’ owners to establish, through the use
of plain text without figures or devices, that would create brand image
in minds of consumers. Especially for tobacco product which its advertising is prohibited in many countries’ laws, brand image will likely
require a longer time and effort until a mark will become distinguishable. Possibly that a mark being limited by force of the health warning
label will also face the same dilemma, the problem in this case will be
very less severe comparing to the plain package as its word marks can
nonetheless indicate and communicate to consumers its origin. Though
the plain packaging measure may be considered legitimate as explained
in the previous chapter, the impact to the acquisition of trademark pro92

See Gervais, supra note 76, at 16.
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tection via use is yet another issue which is a big question to users and
also legislators to dwell.
2. Trademark Use: Registration of a New Mark and Trademark
Infringement (Likelihood of Confusion)
Another issue related to trademark use is the analysis on the level of
similarity appeared in most of the countries’ trademark registration. In
case where a mark in application is consisted of both wording and device, analysis or consideration of a trademark registrar on similarity of
the two marks will generally be on the mark entirely comparing to the
previous ones registered (emphasis added). As the use of a registered
trademark relating to tobacco will now be limited and different from
what they formerly registered with IP office, the question will then be
how a registrar and court will scrutinize the similarity. While there is
much uncertainty under the current system, it is foreseeably that the
solution may base on two different approaches.
First, “as-is” basis, according to this approach, registrars may scrutinize similarity of the two marks basing on documents and samples of
the marks provided without taking the fact of actual use into account.
However, as the trademark use is undeniably related to the scope of
protection and public’s likelihood of confusion, the actual use will then,
to some extent, influence the scrutiny in registrars’ minds, causing them
to possibly switch to the second approach where the consideration will
base on the use of plain text in the case of plain package. According to
TRIPS Article 15.4, this will likely pose a further question on legitimacy of using the registrars’ discretion, the provision reads;

TRIPS: Article 15.4

Art. 15.4 (Protectable Subject Matter)
The nature of the goods or services to which a trademark is to be applied shall in
no case form an obstacle to registration of the trademark
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This paper argues that registrars will likely encounter difficulty of
implementing the second approach, provided that the discretion on
comparing the similarity will likely be in violation of Article 15.4 of
the TRIPS. This is because the focus of comparison is now on the nature of tobacco product. Very much likely that registrars will choose the
“as-is” basis approach, fraudulent applicant may take advantage from
this weakness by creating a mark with fancy device and stylized wording with different spelling and sound, i.e. Marlboro vs. Morlbare, as to
deceive public in terms of origin or source of product that will generally
amount to trademark infringement. As such mark, in comparison to the
registered mark, would be deemed different on its sound and device but
similar in spelling, the all-combined deception, which may entirely appear to be sufficiently distinctive, may cause likelihood of confusion to
public once it is accepted for registration and used on tobacco product
by force of the plain packaging regulation. Will this later case amount
to infringement of the Marlboro trademark as it would likely cause confusion to consumers and mislead public?
Another example that would cause problem on trademark is a generic mark whereby its protection and distinctiveness can acquire through
a combination of stylized wording and devices. When these are all combined together, registrar will usually require an applicant to disclaim on
the generic word partially form and contribute as the whole registered
trademark. As its right of protection will be limited and scoped on any
device and/or components forming an entire registered mark, once it is
registered and applied on a plain package of tobacco, it is hard to imagine how the registrar and court will deal with the situation in practice
when merely an generic word is now appeared on tobacco product by
force of the plain packaging law. Though the provisions are considered legitimate and compatible with the TRIPS, the problem is hard
to imagine and the refusal of a registrar for trademark registration will
also likely amount to the violation of TRIPS Article 15.4. Similar to our
previous analysis, the problem is yet remained to be seen and suggests
Members to beware if they intend to apply the regulation in the future93.
Currently, United Kingdom and New Zealand are considering of adopting tobacco plain
packaging regulation to control tobacco product distributed in the countries; See Voon,
supra note 5, at 118.

93
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3. Trademark Use: Cancellation of Trademark (Non-Use)
In many countries’ national trademark laws, non-use of a registered
trademark may cause cancellation or revocation as trademark is recognized by Paris Convention as industrial property protected for business
purpose. Because of some components of a registered mark that must
be taken down and leave the use to merely on a plain word, question
regarding non-use of components is then arisen if this amounts to a
cancellation. Regarding this particular issue, Australian Tobacco Plain
Packaging Act, explicitly regulates that non-use of a trademark for the
purpose of complying with the Act does not provide a basis for revoking or refusing to register 94. To the extent that this exception clause
applies to both i) revocation of trademark and ii) refusal to register a
trademark based on the reason of non-use , the correlation of this Act
to the Australian trademark law seems to provide a compromising solution to the problem on cancellation but unlikely to the problem on
registration of trademark. Only in the situation where trademark use
is a pre-condition to apply or file for trademark registration that this
clause would benefit, without devices or other compositions, such exception would not change the fact that distinctiveness and brand image
are yet difficult to be created to acquire protection via use in minds
of consumers. Similar to the second problem on registration of a new
mark explained above, this exception clause is seen having limitation
on its scope in implementation. Likely, the health warning label owns
a lesser number of problems in comparison with the plain package imposed by Australia. So, will the stricter regulation always be better? By
taking these impacts on trademark practice into account, whereas the
effectiveness of the regulation is yet suspicious, these may second the
implementing country to re-estimate the measure before adopting radiSee supra note 27, sec. 28(3) provides: “To avoid doubt, for the purposes of sections
38 and 84A of the
Trade Marks Act 1995, and regulations 17A.27 and 17A.42A of the Trade Marks Regulations 1995: (a) the operation of this Act; or (b) the circumstance that a person is prevented,
by or under this Act, from using a trade mark on or in relation to the retail packaging of
tobacco products, or on tobacco products; are not circumstances that make it reasonable
or appropriate: (c) not to register the trade mark; or (d) to revoke the acceptance of an
application for registration of the trade mark; or (e) to register the trade mark subject to
conditions or limitations; or (f) to revoke the registration of the trade mark”.

94
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cal approach on tobacco control such as the plan package. This is unless
the national trademark system is entirely reformed and adjusted for its
full implementation.
4. Trademark Use: The Use of Misleading Word
As the result of tobacco measures, there is also a claim that restriction of the use of trademark will amount to limitation on the use of
components incorporated into a cigarette name, such as “mild”, “light”,
and “ultra-light” descriptors commonly seen in market, that are legitimate and available95. To our notice that tobacco manufacturers and
their affiliated advertisers have strategies to frame the information on
its package, including the shape and size of the package by using such
descriptors96, to create credence qualities in products through design
suggestion and implication to make consumers believed that smoking a
“mild” cigarette, for example, constitutes a positive health measure97,
it is also questionable if such restriction will constitute a trademark infringement98.
Looking the problem from international law perspective, through
the use of TRIPS Article 1.1 and Article 2.199 and Article 6quinquies of
the Paris Convention100, the misleading representations can actually be
See Vadi, supra note 3, at 105-106. “Tobacco company usually claims that the terms
“light”, “mild”, and “low” were incorporated into cigarette names and communicated differences of taste to consumers and such banning would not only destroy valuable trademarks and the goods that they represent but would also tantamount to indirect expropriation”.
96
See Halabi, supra note 59, at 350-351.
97
Id., at 353-355.
98
See Vadi, supra note 3, at 123-124.
99
TRIPS art.2 provides: “In respect of Parts II, III and IV of this Agreement, Members
shall comply with Articles 1 through 12, and Article 19, of the Paris Convention (1967)”.
100
Paris Convention for the Protection of Industrial Property of 1883, 25 Stat. 1372, T.S.
No. 379, 10 Martens Nouveau Recueil 2d 133, revised Dec. 14, 1900, 32 Stat. 1936, T.S.
No. 411, 30 Martens Nouveau Recueil 2d 465, revised June 2, 1911, 38 Stat. 1645, T.S.
No. 579, 8 Martens Nouveau Recueil 3d 760, revised Nov. 6, 1925, 47 Stat. 1789, T.S.
No. 834, 74 L.N.T.S. 289, revised June 2, 1934, 53 Stat. 1748, T.S. No. 941, 192 L.N.T.S.
17, revised Oct. 31, 1958, 13 U.S.T. 1, T.I.A.S. No. 4931, 828 U.N.T.S. 107, revised July
14, 1967, 21 U.S.T. 1583, T.I.A.S. No. 6923, 828 U.N.T.S. 305 [hereinafter Paris Convention] art. 6quinquies.B provides: “Trademarks covered by this Article may be neither
denied registration nor invalidated except in the following cases: (i) when they are of such
95
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rejected by law as it is likely contrary to public order. Particularly in this
issue, there are scholars, through their research, proposed “ex-ante” and
“ex-post” approaches to prevent such unpleasant dilemma 101. To our
notice that only the ex-ante approach that is relevant to our problem of
the misleading representation102, this paper argues that legislation can
thus be used to pose additional requirements of trademark eligibility to
prevent the problem as long as it does not conflict or violate provisions
in TRIPS, namely Articles 15.4 and 20 and by means of Paris Convention Article 6quinquies. By taking Australian Trademark Law103 and
the US’s104, as an example, restriction on the use of misleading words
or waiver of the claim of protection can actually be done by excluding
them from incorporating in a trademark. This thus rebuts the argument
of tobacco companies on the ground of legitimacy. Supported by medical evidence which shows that smokers would likely adopt a “light”
version of a cigarette as a health measure, often as an alternative to quit
smoking105, the current mechanism can therefore provide a perfect solution to the current problem resulted from tobacco measures.
VI. CONCLUSION
The battle and claims of tobacco companies against health warning label and plain packaging regulations adopted in many countries
have highlighted some significant issues concerning TRIPS that we
have overlooked for many years. Many problems argued by tobacco
a nature as to infringe rights acquired by third parties in the country where protection is
claimed; (ii) when they are devoid of any distinctive character, …or have become customary in the current language or in the bona fide and established practices of the trade of the
country where protection is claimed; (iii) when they are contrary to morality or public
order and, in particular, of such a nature as to deceive the public…”.
101
See general Halabi, supra note 59.	
102
Id., at 356-357. The ex-post approach was recently proposed by Prof. Sam Foster
Halabi, College of Law, University of Tulsa.
103
Australia Trademarks Act 1995, sec. 43 provides: “An application for the registration
of a trademark in respect of particular goods or services must be rejected if, because of
some connotation that the trademark or a sign contained in the trademark has, the use of
the trademark in relation to those goods or services would be likely to deceive or cause
confusion”.
104
See Halabi, supra note 59, at 369-370.
105
Id., at 370-371.
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companies are unlikely found in the contents of the TRIPS as priority
of WTO Members in their early negotiation was on the bargain in patent
provisions and the drafters’ willingness to leave it opened for purpose
of flexibility.
To provide analyzing steps to rely on, the Vienna Convention on the
Law of Treaties or VCLT is necessary to be used to project the gist of
the TRIPS and reveal the results of the Members’ negotiations. Among
the eighty five provisions, Articles 31 and 32 are very likely relevant
to our understanding of the provisions in TRIPS by relying on its ordinary meaning in the light of its object and purpose. Together with
previous decisions ruled by the DSB, the analysis revealed that among
other claims, problems are mostly clustered on Articles 15.4, 16, 17 and
20, which is deeply connected to interpretation of justification and necessity under TRIPS Article 8.1. While the tobacco measures are seen
falling under the scope of Article 20 provision, both regulations are
likely found legitimate, justified, and compatible with TRIPS principle
ruled in Article 8.1 as well as the Doha Declaration and the FCTC106
with support from the DSB’s precedents and TRIPS’s history found in
its preparatory works. Moreover, as the provision of TRIPS Article 16
is related to negative right, constituted as the right conferred of trademark holders, and while the tobacco measures under consideration are
not an exception to the right conferred specified thereof, the measures
are therefore considered not in violation of the TRIPS in both Article
16 and 17, as well as Article 15.4 that is regulated to merely prohibit
discrimination on goods basing on nature that will form obstacles to
trademark registration.
Trademark, unlike copyright and patent, is not intendedly protected
to reward trademark creation but rather, it tires to the benefits mutually
shared by manufacturers and also consumers. In review of the gist, i)
the enhancement of fair competition, as to distinguish one’s source or
origin of product (emphasis added) from competitors, and ii) reduction
of consumers’ confusion and information cost are what the law mostly
and profoundly emphasizes on107. Because the trademark law is origiSee Section IV: Legal Analysis on Legitimacy of Health Warning Label and Plain Packaging Regulations under TRIPS, B. Compatibility of the Tobacco Measures with TRIPS.
107
See Halabi, supra note 59, at 365-366.
106
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nally created to prevent consumers’ confusion and to provide fair competition in market, as the result of the tobacco measures, trademarks’
capability of distinguishing origin or source of product is yet observed
to remain though it is transformed into a form of a plain package or
restricted in its size because of the health warning label requirement.
Unless opposers can provide evidence showing that consumers will
likely switch their consumption to a competing or like product in the
same market, the measures would likely be considered legitimate and
compatible to TRIPS where trademark distinctiveness is yet existed and
subject to protection by virtue of the trademark law108.
Notwithstanding the tobacco measures’ legitimacy and compatibility to TRIPS, this paper argues that there shall also be some impacts
resulted from the restriction of trademark use that would likely affect
trademark system in practice. Based on the fact that trademark acquisition, either via registration or use, trademark infringement and also
trademark revocation, are all relying on the actual use of a trademark,
discretion and standard of the courts and registrars in their consideration of trademark acquisition, revocation, and infringement will also
likely be changed in response to the development of tobacco control
measure.
Rather to call for Members’ attention on the impacts, it is not the objective of this paper to oppose any radical implementation of any public health measure or to be against the regulations which aim to bring
healthier population and stronger development in Member countries.
To fully implement public health policy in the WTO Member states
without violating both international and national trademark laws, Members are urged and encouraged to harmonize the systems with holistic
approach, aiming to facilitate domestic health and the flow in trade simultaneously, in order to form a strong and balanced system to benefit
right holders and also users. As previously observed through the use of
Section 28 in Australian Tobacco Plain Packaging Act, though the provision is reserved to be further interpreted, the law is considered to be
a good beginning of founding a harmonized system of trade and IP that
other Member states can take into account. Among different approaches
of tobacco measures such as the plain package and the public health
108

See Vadi, supra note 3, at 122-124.
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warning label, countries may choose either a stricter or more flexible
measure to implement. This is together with the number of unavoidable
impacts that the Members shall always bear in mind.
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